ASBP

Aspire Biopharma Holdings, Inc.

Tüketici (Döngüsel)

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$8.4

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %0.5 / %30

Non-compliant assets / Total market cap %0 / %30

Non-compliant revenue / Total income %94 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Aspire-Lakewood Holdings, Inc. develops sublingual drug delivery technology and manufactures automotive and industrial control systems. The company develops a nano-technology-based sublingual drug delivery system designed to enhance the pharmacokinetic performance of active pharmaceutical ingredients, supplements, and nutraceuticals to increase bioavailability, improve speed of onset, and reduce side effects.

Website

Analysis (Turkish): ASBP Hissesi Caiz mi, Helal mi? Aspire Biopharma Holdings, Inc. Katılım Analizi